Amneal Pharmaceuticals (AMRX)
(Delayed Data from NSDQ)
$7.45 USD
+0.21 (2.90%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $7.45 0.00 (0.00%) 6:50 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Cash flow Statements
Fiscal Year End for AMNEAL PHARMACEUTICALS, INC falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -48.72 | -254.79 | 20.17 | 68.58 | -603.57 |
Depreciation/Amortization & Depletion | 237.58 | 248.77 | 242.61 | 244.07 | 250.11 |
Net Change from Assets/Liabilities | -47.19 | -59.95 | -133.59 | -61.32 | -120.22 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 203.90 | 131.06 | 112.63 | 127.68 | 475.39 |
Net Cash From Operating Activities | 345.58 | 65.10 | 241.82 | 379.00 | 1.71 |
Property & Equipment | -46.80 | -47.80 | -50.94 | -61.84 | -47.18 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -84.71 | -146.54 | -251.36 | 34.83 |
Investments | 0.00 | 0.00 | 5.00 | 0.00 | 0.00 |
Other Investing Activities | -22.39 | -41.80 | -1.70 | -4.35 | -7.23 |
Net Cash from Investing Activities | -69.19 | -174.31 | -194.18 | -317.55 | -19.58 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.45 | 0.66 | 0.85 | 0.32 | -2.14 |
Issuance (Repayment) of Debt | -196.35 | -123.27 | -78.18 | 142.99 | -29.27 |
Increase (Decrease) Short-Term Debt | 219.00 | 85.00 | -1.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -235.68 | -69.01 | -59.80 | -11.50 | -14.42 |
Net Cash from Financing Activities | -212.57 | -106.62 | -138.12 | 131.81 | -45.83 |
Effect of Exchange Rate Changes | 0.07 | -5.68 | 0.10 | 1.04 | -2.25 |
Net Change In Cash & Equivalents | 63.88 | -221.51 | -90.38 | 194.30 | -65.96 |
Cash at Beginning of Period | 35.23 | 256.74 | 347.12 | 152.82 | 218.78 |
Cash at End of Period | 99.11 | 35.23 | 256.74 | 347.12 | 152.82 |
Diluted Net EPS | -0.48 | -0.86 | 0.07 | 0.61 | -2.74 |
Fiscal Year End for AMNEAL PHARMACEUTICALS, INC falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -81.68 | -48.72 | 44.62 | 19.59 |
Depreciation/Amortization & Depletion | NA | 55.82 | 237.58 | 179.35 | 119.78 |
Net Change from Assets/Liabilities | NA | -11.97 | -47.19 | -100.89 | -66.15 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 33.43 | 203.90 | 86.67 | 55.14 |
Net Cash From Operating Activities | NA | -4.41 | 345.58 | 209.75 | 128.37 |
Property & Equipment | NA | -10.06 | -46.80 | -35.01 | -22.53 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | -9.70 | -22.39 | -2.49 | -1.49 |
Net Cash from Investing Activities | NA | -19.76 | -69.19 | -37.50 | -24.02 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.03 | 0.45 | 0.41 | 0.00 |
Issuance (Repayment) of Debt | NA | -15.38 | -196.35 | -152.05 | -87.57 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 219.00 | 110.00 | 100.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -7.81 | -235.68 | -70.10 | -37.59 |
Net Cash from Financing Activities | NA | -23.16 | -212.57 | -111.74 | -25.16 |
Effect of Exchange Rate Changes | NA | -0.17 | 0.07 | -0.14 | 0.17 |
Net Change In Cash & Equivalents | NA | -47.49 | 63.88 | 60.38 | 79.36 |
Cash at Beginning of Period | NA | 99.11 | 35.23 | 35.23 | 35.23 |
Cash at End of Period | NA | 51.62 | 99.11 | 95.61 | 114.58 |
Diluted Net EPS | NA | -0.30 | -0.57 | 0.06 | 0.08 |